tirzepatide cause kidney stones (Zepbound) showed improved function in obese patients with both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https can tirzepatide cause kidney stones

Diabetes, Obesity and Metabolism , 26(3), 445-458

Conclusion: In persons with recently diagnosed T2D, markers of systemic low-grade inflammation were persistently associated with both MACE and all-cause mortality, independent of classical CVD risk factors

was supported in part by F31 AG082504 (to M.F.C.)

Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial

Analog: Its based on a naturally occurring peptide in this case, growth hormone-releasing hormone (GHRH)

By comparing the donor and recipient microbiota and identifying microbial deficiencies in the recipient, compatible donors with matching enterotypes can be selected